Skip to main content
. 2022 Dec 8;9:1030336. doi: 10.3389/fmed.2022.1030336

Table 1.

Non-transplantation-related outcomes in part of studies of Acute-on-Chronic liver failure (ACLF).

References Criterion ACLF grade Non-LT survival/mortality
Moreau et al. (14) EASL CLIF 1-3 The 90-day mortality rate increased from 40.7 to 52.3 to 79.1%
Choudhury et al. (15) APASL AARC I, II, III The 90-day mortality rate is 12.7, 44.5, 85.9%
Artru et al. (16) EASL MELD ≥ 35 The 1-year survival rate is 7.9%
Gustot et al. (17) EASL d3–7 CLIF 3 The 28-day mortality rate is 100%
Zhang et al. (18) COSSH ACLF 2–3 The 28-day survival rate is 6.8%